ARK Israel Innovative Technology ETF (IZRL) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

ARK Israel Innovative Technology ETF (IZRL) Financial Services Profile

The ARK Israel Innovative Technology ETF (IZRL) provides targeted exposure to publicly traded Israeli companies driving transformative innovation across high-growth sectors like genomics, healthcare, biotechnology, industrial production, manufacturing, the Internet, and information technology. It seeks to replicate the performance of the ARK Israeli Innovation Index, offering a focused investment vehicle.

What Is the Investment Thesis for IZRL?

The ARK Israel Innovative Technology ETF (IZRL) offers investors a focused vehicle to gain exposure to Israel's innovative technology sector, a region known for its robust entrepreneurial spirit and significant R&D contributions. With a market capitalization of $138M and a Beta of 0.89, IZRL provides a targeted investment in companies driving transformative innovation across key sectors like healthcare, software, and communications, as defined by the ARK Israeli Innovation Index. The fund's strength lies in its concentrated approach to a country celebrated for technological prowess, potentially benefiting from ongoing advancements and global demand for innovative solutions. However, its concentrated geographic focus presents an ongoing risk, making it vulnerable to regional economic or political instability. Investors should closely monitor the performance of the Israeli tech sector and geopolitical developments, as these factors directly influence the fund's underlying assets and overall performance. The ETF does not pay a dividend, emphasizing its growth-oriented mandate.

Based on FMP financials and quantitative analysis

IZRL Key Highlights

Market Capitalization of $138M, indicating a specialized, niche investment vehicle within the ETF landscape.

• Beta of 0.89, suggesting lower volatility compared to the broader market, potentially offering relative stability.
• No dividend yield, aligning with its growth-oriented strategy focused on capital appreciation from innovative companies.
• Provides targeted exposure to Israeli companies driving transformative innovation across high-growth sectors.
• Replicates the performance of the ARK Israeli Innovation Index, offering a transparent and rules-based investment approach.

Who Are IZRL's Competitors?

IZRL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IZRL's Key Strengths?

Targeted exposure to Israel's highly innovative technology sector, known for its entrepreneurial ecosystem.

• Diversification across multiple high-growth sectors within Israel, including genomics, healthcare, and IT.
• Rules-based index replication strategy offers transparency and consistency.
• Managed by ARK Invest, a firm recognized for its expertise in disruptive innovation.

What Are IZRL's Weaknesses?

Concentrated geographic focus makes the fund vulnerable to regional economic or political instability.

• Relatively small market capitalization ($0.15B) may limit liquidity compared to larger ETFs.
• No dividend yield, which may not appeal to income-focused investors.
• Performance is directly tied to the ARK Israeli Innovation Index, with no active management overlay to mitigate index-specific risks.

What Could Drive IZRL Stock Higher?

Continued strong performance and innovation from Israeli technology companies, driving the underlying index's growth.

• Increased global investor allocation to thematic ETFs focused on innovation and specific geographic regions.
• Potential for new, highly innovative Israeli companies to conduct IPOs and become eligible for inclusion in the ARK Israeli Innovation Index.
• Favorable geopolitical developments in the Middle East region, enhancing investor confidence in Israeli markets.
• Significant technological breakthroughs in genomics, AI, or cybersecurity by Israeli firms, attracting global attention and investment.

What Are the Key Risks for IZRL?

Geopolitical instability and conflict in the Middle East region, which could significantly impact Israeli economic conditions and market sentiment.

• Economic downturns or recessions within Israel, directly affecting the profitability and growth prospects of the underlying companies.
• Underperformance of the ARK Israeli Innovation Index due to sector-specific headwinds or a decline in investor interest in Israeli technology.
• Currency fluctuations between the US dollar and the Israeli New Shekel, which could impact the fund's returns for US investors.
• Market concentration risk due to the fund's exclusive focus on a single country and a specific set of high-growth technology sectors.

What Are the Growth Opportunities for IZRL?

• Growth of Israeli Tech Sector: Israel, often dubbed the 'Startup Nation,' continues to foster a dynamic environment for technological advancement. With a robust venture capital ecosystem, significant government support for R&D, and a high concentration of skilled talent, the sector is projected to expand significantly. This organic growth within the underlying Israeli innovative companies, spanning genomics, healthcare, and IT, directly contributes to the ETF's potential for capital appreciation. As more innovative companies emerge and mature, they may become eligible for inclusion in the ARK Israeli Innovation Index, enhancing the fund's asset base and attracting further investor interest in specialized geographic technology funds. This trend is expected to continue over the next 5-10 years.
• Increased Investor Interest in Thematic ETFs: There is a growing global trend among institutional and retail investors to allocate capital to thematic exchange-traded funds that offer exposure to specific megatrends or innovation themes. IZRL, with its clear focus on Israeli innovation, aligns perfectly with this trend. As investors seek diversification beyond traditional market cap-weighted indices and look for targeted growth opportunities, demand for funds like IZRL is likely to increase. This shift in investment preference, driven by a desire for specialized exposure and potential outperformance in niche sectors, provides a significant tailwind for IZRL's asset under management (AUM) growth over the medium term (3-7 years).
• Diversification Benefits for Global Portfolios: Investing in IZRL offers diversification benefits for global portfolios by providing exposure to a unique geographic and thematic segment. Israeli technology companies often have distinct risk-return profiles compared to those in larger, more mature markets. For investors seeking to reduce correlation with broader market movements or gain access to a less-explored innovation hub, IZRL presents a compelling option. This diversification appeal can attract institutional investors and wealth managers looking to optimize portfolio construction and enhance risk-adjusted returns, thereby contributing to the ETF's AUM growth as part of a broader asset allocation strategy over the long term (5-10 years).
• Innovation in Genomics and Biotechnology: The sectors of genomics and biotechnology are experiencing rapid advancements globally, driven by breakthroughs in gene editing, personalized medicine, and bioinformatics. Israel has a strong presence in these fields, with numerous companies at the forefront of research and development. IZRL's mandate to include companies in these areas positions it to capitalize on the substantial growth potential within these industries. As these technologies mature and find broader applications, the market size for related products and services is expected to expand exponentially, directly benefiting the innovative Israeli companies within IZRL's index. This growth driver is a long-term catalyst, spanning the next decade and beyond.
• Expansion of Industrial Production and IT Innovation: Beyond healthcare and biotech, IZRL also targets Israeli companies driving innovation in industrial production, manufacturing, the Internet, and information technology. These sectors are undergoing transformative changes driven by automation, artificial intelligence, cybersecurity, and cloud computing. Israel's expertise in these areas, particularly in cybersecurity and enterprise software, positions companies within the index to capture significant market share in evolving global industries. The continuous demand for advanced industrial solutions and cutting-edge IT infrastructure provides a sustained growth opportunity for the ETF's underlying holdings, contributing to its performance over the medium to long term (5-10 years).

What Threats Does IZRL Face?

• Geopolitical instability and conflict in the Middle East region could negatively impact Israeli markets.
• Economic downturns or regulatory changes in Israel could adversely affect underlying company performance.
• Competition from other global technology ETFs or country-specific funds offering similar exposure.
• Underperformance of the ARK Israeli Innovation Index relative to broader market benchmarks.

What Are IZRL's Competitive Advantages?

• Specialized geographic and thematic focus on Israeli innovative technology companies.
• Proprietary ARK Israeli Innovation Index methodology, defining its unique investment universe.
• Association with the ARK Invest brand, known for its focus on disruptive innovation.
• Diversification benefits within a single fund, offering a basket of innovative Israeli firms.

What Does IZRL Do?

The ARK Israel Innovative Technology ETF, identified by its ticker IZRL, is a financial product designed to mirror the financial performance of the ARK Israeli Innovation Index, before accounting for any associated fees and expenses. Established with a clear mandate, IZRL provides investors with a specialized avenue to access the dynamic Israeli technology landscape. The underlying ARK Israeli Innovation Index is meticulously constructed to monitor the stock fluctuations of Israeli companies that are publicly traded and whose core business activities are centered on driving transformative innovation. These innovative efforts span a diverse array of high-growth sectors critical to the global economy. Specifically, the fund targets companies involved in genomics, a field focused on the structure, function, evolution, and mapping of genomes; healthcare, encompassing advancements in medical technology and services; biotechnology, which applies biological processes for industrial and other purposes; industrial production, involving advanced manufacturing techniques; and the expansive domains of the Internet and information technology. Headquartered in Saint Petersburg, US, IZRL operates within the Asset Management - Global industry, offering a unique thematic and geographic investment proposition. The ETF's strategy is rooted in identifying and tracking companies that are considered to be at the forefront of technological advancement within Israel, a nation widely recognized for its entrepreneurial ecosystem and significant contributions to global innovation.

What Products and Services Does IZRL Offer?

• Replicates the performance of the ARK Israeli Innovation Index, before fees and expenses.
• Invests in publicly traded Israeli companies focused on transformative innovation.
• Provides exposure to high-growth sectors including genomics, healthcare, and biotechnology.
• Includes companies involved in industrial production, manufacturing, the Internet, and information technology.
• Offers a single-country, thematic investment vehicle for accessing Israeli technological advancements.
• Operates as an exchange-traded fund (ETF), providing liquidity and diversification within its mandate.

How Does IZRL Make Money?

• Generates revenue primarily through management fees charged to investors for managing the fund.
• Aims to achieve capital appreciation by tracking the performance of its underlying index.
• Provides a diversified basket of Israeli innovation stocks, reducing single-stock risk for investors.
• Offers a transparent, rules-based investment approach by replicating a defined index.

What Industry Does IZRL Operate In?

The ARK Israel Innovative Technology ETF (IZRL) operates within the Asset Management - Global industry, specifically targeting the thematic ETF segment. This segment has seen significant growth as investors increasingly seek specialized exposure to high-growth trends and specific geographic markets. IZRL positions itself by focusing exclusively on Israeli companies engaged in transformative innovation, differentiating it from broader technology or international equity ETFs. The competitive landscape includes other country-specific or thematic technology ETFs, but IZRL's unique index methodology and ARK's brand in innovation-focused investing provide a distinct niche. The global asset management industry is characterized by increasing demand for transparent, liquid, and cost-effective investment solutions like ETFs, particularly those offering access to unique growth stories in emerging innovation hubs such as Israel. IZRL taps into the global trend of seeking alpha through specialized, actively managed (or index-tracking with an active philosophy) portfolios.

Who Are IZRL's Key Customers?

• Institutional investors seeking specialized exposure to Israeli technology.
• Retail investors looking for thematic growth opportunities in innovation.
• Financial advisors and wealth managers constructing diversified client portfolios.
• Investors interested in gaining exposure to the 'Startup Nation' economy.

Return on equity for ARK Israel Innovative Technology ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. IZRL trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

How ARK Israel Innovative Technology ETF Is Valued

ARK Israel Innovative Technology ETF carries a market capitalization of $138M, placing it in the micro-cap category. Relative to its peer group, IZRL's quantitative score of 47/100 is roughly in line with the peer average of 51/100.

IZRL Financials

IZRL Latest News

No recent news available for IZRL.

IZRL Analyst Consensus

IZRL MoonshotScore

ARK Israel Innovative Technology ETF Financial Services Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources